RVNC
HEALTHCARERevance Therapeutics Inc
—PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving RVNC Today?
No stock-specific AI insight has been generated for RVNC yet. Check back soon — insights are generated from recent news analysis.
0
Fundamentals
Market Cap$381M
P/E Ratio—
EPS$-3.34
Dividend Yield—
Dividend / Share—
ROE-21.0%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding104.4M
RVNC News
No news articles found for RVNC yet.
Price Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High$0.00
52 Week Low$0.00
Fundamentals
Market Cap$381M
P/E Ratio—
EPS$-3.34
Dividend Yield—
Dividend / Share—
ROE-21.0%
Profit Margin-0.7%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding104.4M
About Revance Therapeutics Inc
Revance Therapeutics, Inc., a biotechnology company, is dedicated to the development, manufacture, and marketing of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company is headquartered in Newark, California.
Listed February 6, 2014
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—